DRUG
Bright Minds Biosciences Inc. NASDAQ Listed Mar 22, 2021$60.98
-0.93%
vs $61.55
Mkt Cap $419.4M
52w Low $50.10
23.7% of range
52w High $95.99
50d MA $73.40
200d MA $77.86
P/E (TTM)
-22.1x
EV/EBITDA
—
P/B
5.1x
Debt/Equity
0.0x
ROE
—
P/FCF
-48.3x
RSI (14)
22.10
ATR (14)
$2.87
Beta
-0.11
50d MA
$73.40
200d MA
$77.86
Avg Volume
115.3K
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
1500 – 1055 West Georgia Street · New York City, BC V6E 4N7 · CA
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | AMC | -1.39 | -0.17 | +87.8% | 79.48 | +0.0% | +5.7% | +0.8% | -7.3% | -1.5% | -0.5% | — |
| May 20, 2026 | AMC | -1.06 | -0.80 | +24.5% | 82.78 | -1.8% | +0.6% | +0.3% | +3.3% | +0.9% | +2.8% | — |
| May 19, 2026 | AMC | -0.92 | -0.80 | +12.7% | 74.54 | +3.3% | +11.1% | +0.6% | +0.3% | +3.3% | +0.9% | — |
| Feb 12, 2026 | AMC | -0.98 | -0.70 | +28.6% | 80.57 | +0.3% | -3.3% | +7.7% | -4.3% | +7.2% | -0.7% | — |
| Dec 23, 2025 | AMC | -0.56 | -0.41 | +27.1% | 84.27 | +0.5% | +0.5% | -3.0% | -4.9% | -2.9% | +2.9% | — |
| Aug 14, 2025 | AMC | -0.59 | -0.53 | +10.2% | 42.54 | +2.1% | -1.7% | +8.9% | -6.4% | +0.9% | -2.1% | — |
| May 15, 2025 | AMC | -0.39 | -0.29 | +25.6% | 32.36 | -0.6% | +2.0% | -3.1% | +1.5% | -6.3% | -0.7% | — |
| Feb 13, 2025 | AMC | -0.23 | 0.01 | +104.3% | 45.72 | -1.7% | -8.6% | -10.3% | -0.3% | -3.3% | -0.4% | — |
| Dec 30, 2024 | AMC | -0.44 | -0.12 | +72.9% | 36.86 | +2.3% | -2.3% | +14.1% | -3.1% | +3.9% | -2.9% | — |
| Aug 14, 2024 | AMC | — | 0.04 | — | 1.01 | +4.0% | +2.0% | +3.9% | -4.7% | -1.0% | +2.0% | — |
| May 15, 2024 | AMC | — | -0.10 | — | 1.09 | +0.9% | -2.8% | +3.8% | -0.9% | +11.9% | -7.4% | — |
| Feb 12, 2024 | AMC | — | -0.32 | — | 1.90 | +4.2% | +1.6% | +1.6% | +0.0% | -0.5% | -4.1% | — |
| Dec 29, 2023 | AMC | — | -0.30 | — | 1.43 | +4.2% | +28.7% | -9.2% | +2.4% | -0.6% | +10.6% | — |
| Aug 14, 2023 | AMC | — | -0.29 | — | 2.42 | -2.5% | +9.5% | -2.6% | -0.4% | +2.3% | -0.8% | — |
| May 15, 2023 | AMC | — | -0.08 | — | 2.70 | +0.4% | +4.4% | -1.1% | -6.5% | -3.1% | +1.6% | — |
| Feb 7, 2023 | AMC | — | -0.10 | — | 4.10 | -1.7% | -4.9% | -6.4% | +2.7% | -1.1% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 | BTIG | Maintains | Buy → Buy | — | $70.10 | $70.89 | +1.1% | -2.4% | +6.6% | -1.7% | -0.4% | +4.9% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $80.00 | $80.00 | +0.0% | -0.9% | -1.9% | -1.2% | +4.7% | -1.0% |
| Feb 17 | BTIG | Maintains | Buy → Buy | — | $77.90 | $77.60 | -0.4% | +7.7% | -4.3% | +7.2% | -0.7% | +1.2% |
| Jan 7 | BTIG | Maintains | Buy → Buy | — | $93.21 | $91.64 | -1.7% | +3.0% | -6.2% | -3.6% | +2.2% | +0.8% |
| Jan 6 | BTIG | Maintains | Buy → Buy | — | $80.01 | $119.80 | +49.7% | +16.5% | +3.0% | -6.2% | -3.6% | +2.2% |
| Jan 2 | Chardan Capital | Maintains | Buy → Buy | — | $78.04 | $79.51 | +1.9% | +6.9% | -4.1% | +16.5% | +3.0% | -6.2% |
| Dec 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $78.12 | $78.26 | +0.2% | -2.9% | +2.9% | +6.9% | -4.1% | +16.5% |
| Sep 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $48.75 | $48.80 | +0.1% | -0.2% | -6.6% | -1.7% | +12.2% | +6.2% |
| Aug 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $45.55 | $46.13 | +1.3% | -6.4% | +0.9% | -2.1% | +4.3% | -5.1% |
| May 21 | Chardan Capital | Maintains | Buy → Buy | — | $32.46 | $32.10 | -1.1% | -6.3% | -0.7% | -4.0% | -5.4% | -0.3% |
| Feb 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.51 | $37.07 | -1.2% | -0.3% | -3.3% | -0.4% | -0.1% | -5.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Cormorant Asset Management, LP | — | Sell | 109,331 | $89.50 | $9.8M | 950,000 | -1.13% | +0.09% |
No recent filings available.
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 11
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | BlackRock Health Sciences Opportunities Portfolio | 95,655 | $8M | May 2026 |
| 2 | AdvisorShares Psychedelics ETF | 24,274 | $2M | Jun 2026 |
| 3 | Adara Smaller Companies Fund | 20,238 | $2M | Feb 2026 |
| 4 | Goldman Sachs Small Cap Growth Insights Fund | 3,458 | $269K | Jan 2026 |
| 5 | Small Cap Index Fund | 3,805 | $267K | Jun 2026 |
| 6 | Goldman Sachs Small Cap Equity Insights Fund | 3,139 | $244K | Jan 2026 |
| 7 | Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 2,740 | $241K | May 2026 |
| 8 | Penn Series Small Cap Index Fund | 100 | $7K | Mar 2026 |
| 9 | Russell 2000 Fund | 16 | $1K | Mar 2026 |
| 10 | Russell 2000 1.5x Strategy Fund | 9 | $657 | Mar 2026 |
| 11 | Russell 2000(R) 1.5x Strategy Fund | 2 | $140 | Jun 2026 |
Valuation
Market Cap
$419.4M
Enterprise Value
$336.5M
P/E (TTM)
-22.09x
Forward P/E
—
PEG Ratio
-0.27x
P/B
5.11x
P/S
—
P/FCF
-48.26x
EV/EBITDA
—
Shares Out
6.9M
Financials (TTM)
Revenue
$0
Net Income
-$24.7M
EBITDA
-$33.9M
Free Cash Flow
-$8.7M
Op Cash Flow
-$8.7M
EPS Basic
$-1.78
EPS Diluted
$-2.76
EPS Forward
$-6.78
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$84.4M
Total Liab.
$2.4M
Total Equity
$82.0M
Cash
$82.9M
LT Debt
$0
Book Value/Sh
$11.93
Debt/Equity
0.00x
Current Ratio
36.10
Quick Ratio
36.10
Returns & Growth
ROE
—
ROA
—
ROIC
-17.0%
Rev Growth YoY
+0.0%
EPS Growth YoY
-173.8%
Price Returns
2W
-13.5%
1M
-26.8%
3M
+1.5%
6M
-11.9%
12M
+22.7%
Technicals
52W High
$95.99
52W Low
$50.10
50d MA
$73.40
200d MA
$77.86
RSI (14)
22.10
ATR (14)
$2.87
Beta
-0.11
Avg Volume
115K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$136.50
High
$147.00
Low
$126.00
Median
$136.50
Data updated apr 25, 2026 5:48am
· Source: financialmodelingprep.com